Global Drug Eluting Beads Market by Type (Oncozene Beads, Quadra Sphere, LC Beads, Others), By Application (Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The global drug-eluting beads market is projected to grow at a CAGR of 5.6% during the forecast period and is predicted to be worth US$ 2.3 billion by 2028. The growth in this industry can be attributed to factors such as the increasing number of surgeries, the introduction of new products with enhanced efficacy, rising prevalence rates of cancer worldwide, and growing acceptance among patients for minimally invasive procedures. In the near future, it will become more cost-effective for hospitals to use these devices instead of other surgical methods that are more expensive and time-consuming.
Drug-eluting beads are tiny, biocompatible particles that contain a therapeutic agent and coated with an outer layer of polymer. The drug is released as the bead dissolves over time. They can be used to treat cancerous tumors in patients who have difficulty undergoing surgery or other treatment options due to their health conditions. Drug-eluting beads were initially introduced by Angiodynamics Inc., which was acquired by Boston Scientific Corporation in 1998 for US$ 301 million.
On the basis of type, the drug-eluting beads market is segmented into oncozene beads, quadra sphere, LC Beads, and others.
Oncozene beads
Oncozene beads, a type of drug-eluting bead, are used for the treatment of cancerous tumors. These biocompatible particles contain chemotherapeutic agents which deliver tumor-killing drugs to affected areas via sustained release over time in order to reduce side effects of traditional treatments and improve outcomes. They have been approved by FDA for use as an alternative treatment option for patients with colorectal cancer who cannot undergo surgery or radiation therapy due to their health conditions like severe chronic obstructive pulmonary disease (COPD), heart failure (HF), advanced age (> 75 years old) or other serious comorbidities such as diabetes mellitus (DM). oncozene Beads consist of either single-drug coated beads or multi-drug coated beads. They are available in both soft shell (polymer) and hard shell (ceramic) varieties depending upon dosage requirements.
Quadra sphere
Quadra sphere consists of four spherical beads, each with its own release rate and polymer coating for the therapeutic agent. quadra spheres are used to treat cancerous tumors in patients who have difficulty undergoing surgery or other treatment options due to their health conditions. The technology behind this product offers increased convenience as it eliminates the need for doctors to administer multiple injections at different points on a patient’s tumor site during surgical procedures.
LC beads
LC beads are a type of drug-eluting bead that is coated with liquid-crystal polymer. They are biocompatible particles that contain a therapeutic agent and coated with an outer layer of polymer. The unique structure and properties of LC coating allow for prolonged release, as well as protection from degradation. This makes it an ideal candidate for the treatment of cancerous cells lodged in difficult to reach or sensitive areas such as brain tumors.
On the basis of application drug-eluting beads are segmented into hospitals, specialized clinics, research centers, and ambulatory surgical centers.
Hospitals
Drug-eluting beads have been used in hospitals since the 1970s for a variety of purposes. They were first designed to aid and prolong surgery by reducing bleeding, infection rates, and post-surgical recovery time. As they became more advanced over time, drug-eluting bead technology has also helped doctors perform minimally invasive surgeries with less pain due to reduced scarring or adhesion formation. For patients who need immediate relief from inflammation caused by wounds or fractures that are difficult to heal on their own, hydrogels may be useful as an alternative treatment option while waiting for other procedures like bone grafting or joint replacement surgery.
Specialized clinics
Drug-eluting beads in specialized clinics are used to stimulate the growth of new bone tissue. This is done by inserting a drug-coated balloon into an area where there has been damage due to trauma, tumor removal, or other causes that have led to the loss of healthy supporting bone. The bead contains osteogenic drugs like BMPs and IGFs which promote the production of new cells from existing ones in order to form new bones. These agents encourage cell division and differentiation so that they can eventually replace lost tissues with newly formed bony structures better able to support their weight and help maintain muscle activity levels during physical therapy sessions.
Research centers
Drug-eluting beads are also used in research centers where they provide the ability to more precisely control and monitor levels of drug release. This is especially useful when researchers want to explore how different doses affect cell proliferation or need a controlled environment for experiments with live cells. Traditionally, this type of experimentation was done on animals but thanks to advances in technology it can now be conducted using human cells without harming an animal. In addition to benefiting academic institutions that perform research into biomedicine, these advancements could mean cheaper costs for developing drugs with potential market success because fewer prototypes will have been tested on animals before coming onto the commercial market. In turn, this would reduce dependence on laboratory animals as well as lower associated regulatory costs related to animal welfare.
Ambulatory surgical centers
The use of drug-eluting beads in ambulatory surgical centers is widely used to treat a number of cancers. The application provides an opportunity to administer the treatment via a catheter, which can be inserted into any part of the body through a small incision and for short periods without compromising on efficacy or side effects. This helps patients who cannot get surgery due to other health conditions such as heart disease and diabetes making it easy for them to receive therapies that they may not have otherwise been able to afford or access easily before.
On the basis of region, the drug-eluting market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
North America is expected to dominate the drug-eluting market in near future due to the high prevalence of cancer cases coupled with high awareness about new therapies such as hormone therapy among people living there which will result in greater demand for medical devices used for treatment. Asia Pacific region follows closely behind North American region followed by Europe owing to a rapid increase in the number of incidences of diseases along with the increasing level of investment in research activities.
Growth factors
The growth factors of the drug-eluting market are increasing awareness among the people about various types of treatment and a rise in demand for minimally invasive surgery. The major factor driving this growth is a rise in cancer rates, which has led to an increase in surgical procedures such as radiotherapy, chemotherapy, and proton therapy.
Up Market Research published a new report titled “Drug Eluting Beads Market research report which is segmented by Types (Oncozene Beads, Quadra Sphere, LC Beads, Others), By Applications (Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers), By Players/Companies Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Drug Eluting Beads Market Research Report |
| By Type | Oncozene Beads, Quadra Sphere, LC Beads, Others |
| By Application | Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers |
| By Companies | Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 245 |
| Number of Tables & Figures | 172 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Drug Eluting Beads Market Report Segments:
The market is segmented by Type Oncozene Beads, Quadra Sphere, LC Beads, Others and By Application Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers.
Some of the companies that are profiled in this report are:
- Biocompatibles
- BTG International
- Merit Medical Systems
- CeloNova BioSciences
- ABK Biomedical
- Boston Scientific
- Medtronic
- Merit Medical Systems
- Surefire Medical
- Terumo
Drug Eluting Beads Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Eluting Beads Market
Overview of the regional outlook of the Drug Eluting Beads Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Drug Eluting Beads Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Drug Eluting Beads Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Oncozene Beads
2. Quadra Sphere
3. LC Beads
4. Others
7. By Application:1. Hospitals
2. Specialized Clinics
3. Research Centers
4. Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Beads Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Drug Eluting Beads Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Beads Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Beads Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Beads Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Beads Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Beads Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Beads Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Beads Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Beads Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Beads Market Size Forecast by Type
5.2.1 Oncozene Beads
5.2.2 Quadra Sphere
5.2.3 LC Beads
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Beads Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Beads Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Clinics
6.2.3 Research Centers
6.2.4 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Beads Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Beads Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Beads Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Beads Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Beads Market Size Forecast by Type
9.6.1 Oncozene Beads
9.6.2 Quadra Sphere
9.6.3 LC Beads
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Beads Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Clinics
9.10.3 Research Centers
9.10.4 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Beads Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Beads Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Beads Market Size Forecast by Type
10.6.1 Oncozene Beads
10.6.2 Quadra Sphere
10.6.3 LC Beads
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Beads Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Clinics
10.10.3 Research Centers
10.10.4 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Beads Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Beads Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Beads Market Size Forecast by Type
11.6.1 Oncozene Beads
11.6.2 Quadra Sphere
11.6.3 LC Beads
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Beads Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Clinics
11.10.3 Research Centers
11.10.4 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Beads Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Beads Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Beads Market Size Forecast by Type
12.6.1 Oncozene Beads
12.6.2 Quadra Sphere
12.6.3 LC Beads
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Beads Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Clinics
12.10.3 Research Centers
12.10.4 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Beads Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Type
13.6.1 Oncozene Beads
13.6.2 Quadra Sphere
13.6.3 LC Beads
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Clinics
13.10.3 Research Centers
13.10.4 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Beads Market: Competitive Dashboard
14.2 Global Drug Eluting Beads Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocompatibles
14.3.2 BTG International
14.3.3 Merit Medical Systems
14.3.4 CeloNova BioSciences
14.3.5 ABK Biomedical
14.3.6 Boston Scientific
14.3.7 Medtronic
14.3.8 Merit Medical Systems
14.3.9 Surefire Medical
14.3.10 Terumo
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Beads Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Beads Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Beads Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Beads Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Beads Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Beads Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Beads Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Beads Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Beads Market Size Forecast by Type
5.2.1 Oncozene Beads
5.2.2 Quadra Sphere
5.2.3 LC Beads
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Beads Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Beads Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Clinics
6.2.3 Research Centers
6.2.4 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Beads Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Beads Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Beads Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Beads Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Beads Market Size Forecast by Type
9.6.1 Oncozene Beads
9.6.2 Quadra Sphere
9.6.3 LC Beads
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Beads Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Clinics
9.10.3 Research Centers
9.10.4 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Beads Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Beads Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Beads Market Size Forecast by Type
10.6.1 Oncozene Beads
10.6.2 Quadra Sphere
10.6.3 LC Beads
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Beads Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Clinics
10.10.3 Research Centers
10.10.4 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Beads Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Beads Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Beads Market Size Forecast by Type
11.6.1 Oncozene Beads
11.6.2 Quadra Sphere
11.6.3 LC Beads
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Beads Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Clinics
11.10.3 Research Centers
11.10.4 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Beads Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Beads Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Beads Market Size Forecast by Type
12.6.1 Oncozene Beads
12.6.2 Quadra Sphere
12.6.3 LC Beads
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Beads Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Clinics
12.10.3 Research Centers
12.10.4 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Beads Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Type
13.6.1 Oncozene Beads
13.6.2 Quadra Sphere
13.6.3 LC Beads
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Clinics
13.10.3 Research Centers
13.10.4 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Beads Market: Competitive Dashboard
14.2 Global Drug Eluting Beads Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocompatibles
14.3.2 BTG International
14.3.3 Merit Medical Systems
14.3.4 CeloNova BioSciences
14.3.5 ABK Biomedical
14.3.6 Boston Scientific
14.3.7 Medtronic
14.3.8 Merit Medical Systems
14.3.9 Surefire Medical
14.3.10 Terumo
Segments Covered in the Report
The global Drug Eluting Beads market has been segmented based on
By Types
The global Drug Eluting Beads market has been segmented based on
By Types
- Oncozene Beads
- Quadra Sphere
- LC Beads
- Others
- Hospitals
- Specialized Clinics
- Research Centers
- Ambulatory Surgical Centers
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Biocompatibles
- BTG International
- Merit Medical Systems
- CeloNova BioSciences
- ABK Biomedical
- Boston Scientific
- Medtronic
- Merit Medical Systems
- Surefire Medical
- Terumo
Our Clients
Related Reports
Some other reports from this category!
